Table 3.

Univariate and multivariate analyses of clinicopathological parameters for the prediction of OS in the patients with colorectal cancer

		Univariate analysis		Multivariate analysis
		HR (95.0%CI)	p	HR (95.0%CI)	p
Age		1.028 (0.995–1.062)	0.099	1.030 (0.993–1.069)	0.118
Sex	(male vs female)	1.867 (0.774–4.506)	0.165	1.376 (0.488–3.883)	0.547
Tumor size		1.149 (0.965–1.367)	0.119	1.198 (0.970–1.480)	0.093
T	T1	1	0.351	1
	T2 (2 vs 1)	0.289 (0.018–4.646)	0.381	0.197 (0.011–3.597)	0.273
	T3 (3 vs 1)	1.737 (0.231–13.058)	0.592	0.772 (0.082–7.284)	0.821
	T4 (4 vs 1)	1.727 (0.192–15.551)	0.626	0.663 (0.061–7.243)	0.736
N	N0	1	0.246	1
	N1 (1 vs 0)	1.614 (0.600–4.339)	0.343	0.994 (0.192–5.136)	0.994
	N2 (2 vs 0)	2.242 (0.864–5.817)	0.097	1.301 (0.189–8.977)	0.789
PN invasion	Positive vs negative	1.771 (0.786–3.988)	0.168	1.376 (0.483–3.920)	0.550
LV invasion	Positive vs negative	2.133 (0.947–4.805)	0.068	1.747 (0.306–9.982)	0.531
Hemoglobin		1.007 (0.819–1.237)	0.947	1.042 (0.792–1.371)	0.770
Albumin		0.630 (0.322–1.231)	0.177	0.958 (0.390–2.352)	0.926
Groups	(NLR>3 vs NLR≤3)	3.003 (1.189–7.589)	0.020*	3.055 (1.080–8.638)	0.035*

OS: overall survival; PN: perineural invasion; LV: lymphovascular; T: tumour size staging; N: lymph node metastasis staging; HR: hazard ratio; CI: confidence interval

^*p<0.05